OpenAlex
PricingAboutJobs
Log inGet started
Work

A new dawn for managing dyslipidemias: The era of rna-based therapies

HTML

Year: 2019
Type: review
Source: Pharmacological Research
DOI: 10.1016/j.phrs.2019.104413
Authors: C. Macchi, C.R. Sirtori, A. Corsini, R.D. Santos, G.F. Watts, M. Ruscica
Institutions: University of Milan, Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, MultiMedica, Universidade de São Paulo, Hospital Israelita Albert Einstein, Instituto do Coração - HCFMUSP, The University of Western Australia, Royal Perth Hospital
Language: English

Topic: Lipoproteins and Cardiovascular Health
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Keywords: RNA therapeutics, dyslipidemia, atherosclerotic cardiovascular disease, PCSK9 inhibition, inclisiran, mipomersen, apolipoprotein B, lipoprotein(a), antisense oligonucleotides, volanesorsen, apolipoprotein C-III, ANGPTL3, triglyceride-rich lipoproteins, LDL cholesterol lowering, residual cardiovascular risk, lipid metabolism
SDG: Good health and well-being

Open Access status: bronze

Funders: International Atherosclerosis Society, Fondazione Cariplo, Conselho Nacional de Desenvolvimento Científico e Tecnológico
Awards: G1404201447, G4574909456, Aged-related obesity and chronic immuno-inflammation: understanding the relevance and pathophysiology of lactate
OpenAlex ID: W2969846379
FWCI: 2.486
Cites: 135
Cited by: 99
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security